Association between pharmacotherapy and secondary vertebral fracture managed with a brace in a real-world setting: A nationwide database study in Japan.

Shinichi NakatohKenji FujimoriShigeyuki IshiiJunko TamakiNobukazu OkimotoSumito OgawaMasayuki Iki

Published in: Geriatrics & gerontology international (2024)

Patients taking medications were at a lower risk of developing SVF than those not taking medications. Although this study did not compare the medications' SVF prevention effects, patients taking denosumab had a 0.77 SIR of SVF in Japan. The effect of pharmacotherapy on SVF prevention might be affected by the MPR of each medication. Geriatr Gerontol Int 2024; 24: 390-397.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
emergency department
patient reported outcomes
bone mineral density
body composition